Annual EBITDA
$5.32B$624.70M+13.31%
Summary
- Current Value
- As of today, REGN annual EBITDA is $5.32B, up +13.31% on
- Historical Performance
- REGN annual EBITDA is down -45.00% over the past 3 years, and up +99.21% over the past 5 years
- All-Time High Comparison
- REGN annual EBITDA is currently -45.00% below its historical high of $9.67B set on
- 3-Year Low Comparison
- REGN annual EBITDA is +13.31% above its 3-year low of $4.69B reached on
- Sector Comparison
- REGN annual EBITDA is higher than 98.04% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $5.32B | +13.3% | -45.0% | +99.2% | +9704.8% | |
| Quarterly EBITDA | $1.25B | -8.2% | -5.3% | +12.1% | +4683.1% | |
| TTM EBITDA | $4.36B | -5.5% | -35.7% | +31.4% | +4234.0% | |
| Price | $741.45 | +8.6% | +0.7% | +47.2% | +2116.6% | |
| PE Ratio | 17.75 | -0.5% | -7.8% | +8.1% | – | |
| Annual Revenue | $14.20B | +8.3% | -11.6% | +116.6% | +3644.6% | |
| Annual EPS | $38.34 | +10.3% | -46.7% | +107.7% | +4610.3% | |
| $4.84B | +13.2% | -48.5% | +96.6% | +7045.5% | ||
| Annual Net Income | $4.41B | +11.6% | -45.4% | +108.5% | +6605.4% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $5.32B | at high | |
| 5Y | $9.67B | -45.0% | |
| All | $9.67B | -45.0% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $4.69B | +13.3% | |
| 5Y | $4.10B | N/A | +29.6% |
| All | -$170.53M | +3218.6% |
EBITDA History
FAQ
What is the current annual EBITDA of REGN?
As of today, REGN annual EBITDA is $5.32B
What is 1-year change in REGN annual EBITDA?
REGN annual EBITDA is up +13.31% year-over-year
What is 3-year change in REGN annual EBITDA?
REGN annual EBITDA is down -45.00% over the past 3 years
How far is REGN annual EBITDA from its all-time high?
REGN annual EBITDA is currently -45.00% below its historical high of $9.67B set on December 31, 2021
How does REGN annual EBITDA rank versus sector peers?
REGN annual EBITDA is higher than 98.04% of companies in Healthcare sector
When is REGN next annual earnings release?
The next annual earnings release for REGN is on
Quarterly EBITDA
$1.25B$22.00M+1.80%
Summary
- Current Value
- As of today, REGN quarterly EBITDA is $1.25B, up +1.80% on
- Historical Performance
- REGN quarterly EBITDA is down -8.16% year-over-year, and down -5.30% over the past 3 years
- All-Time High Comparison
- REGN quarterly EBITDA is currently -63.53% below its historical high of $3.42B set on
- 3-Year Low Comparison
- REGN quarterly EBITDA is +70.56% above its 3-year low of $730.90M reached on
- Sector Comparison
- REGN quarterly EBITDA is higher than 97.73% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $1.25B | +1.8% | -8.2% | -5.3% | +12.1% | |
| Annual EBITDA | $5.32B | – | +13.3% | -45.0% | +99.2% | |
| TTM EBITDA | $4.36B | -2.5% | -5.5% | -35.7% | +31.4% | |
| Price | $741.45 | +13.4% | +8.6% | +0.7% | +47.2% | |
| PE Ratio | 17.75 | +13.3% | -0.5% | -7.8% | +8.1% | |
| Quarterly Revenue | $3.75B | +2.1% | +0.9% | +27.9% | +63.7% | |
| Quarterly EPS | $13.62 | +6.3% | +18.1% | +16.8% | +84.2% | |
| $1.11B | +1.9% | -10.2% | -9.3% | +5.4% | ||
| Quarterly Net Income | $1.46B | +4.9% | +8.9% | +11.0% | +73.4% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.25B | at high | |
| 3Y | $1.42B | N/A | -11.9% |
| 5Y | $3.42B | -63.5% | |
| All | $3.42B | -63.5% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $730.90M | +70.6% | |
| 3Y | $730.90M | +70.6% | |
| 5Y | $730.90M | +70.6% | |
| All | -$52.42M | +2478.2% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of REGN?
As of today, REGN quarterly EBITDA is $1.25B
What is REGN quarterly EBITDA most recent change?
REGN quarterly EBITDA was up +1.80% on September 30, 2025
What is 1-year change in REGN quarterly EBITDA?
REGN quarterly EBITDA is down -8.16% year-over-year
How far is REGN quarterly EBITDA from its all-time high?
REGN quarterly EBITDA is currently -63.53% below its historical high of $3.42B set on June 30, 2021
How does REGN quarterly EBITDA rank versus sector peers?
REGN quarterly EBITDA is higher than 97.73% of companies in Healthcare sector
When is REGN next earnings release?
The next earnings release for REGN is on
TTM EBITDA
$4.36B$110.80M-2.48%
Summary
- Current Value
- As of today, REGN TTM EBITDA is $4.36B, down -2.48% on
- Historical Performance
- REGN TTM EBITDA is down -5.49% year-over-year, and down -35.70% over the past 3 years
- All-Time High Comparison
- REGN TTM EBITDA is currently -53.74% below its historical high of $9.41B set on
- 3-Year Low Comparison
- REGN TTM EBITDA is at its 3-year low
- Sector Comparison
- REGN TTM EBITDA is higher than 97.45% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $4.36B | -2.5% | -5.5% | -35.7% | +31.4% | |
| Annual EBITDA | $5.32B | – | +13.3% | -45.0% | +99.2% | |
| Quarterly EBITDA | $1.25B | +1.8% | -8.2% | -5.3% | +12.1% | |
| Price | $741.45 | +13.4% | +8.6% | +0.7% | +47.2% | |
| PE Ratio | 17.75 | +13.3% | -0.5% | -7.8% | +8.1% | |
| TTM Revenue | $14.25B | +0.2% | +2.9% | +3.9% | +79.5% | |
| TTM EPS | $41.77 | +5.3% | +3.4% | -11.9% | +52.6% | |
| $3.83B | -3.2% | -7.5% | -40.7% | +24.1% | ||
| TTM Net Income | $4.58B | +2.7% | -1.6% | -14.8% | +45.1% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $4.60B | N/A | -5.3% |
| 3Y | $5.47B | N/A | -20.4% |
| 5Y | $9.41B | -53.7% | |
| All | $9.41B | -53.7% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $4.36B | at low | |
| 3Y | $4.36B | at low | |
| 5Y | $3.81B | N/A | +14.2% |
| All | -$174.08M | +2601.8% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of REGN?
As of today, REGN TTM EBITDA is $4.36B
What is REGN TTM EBITDA most recent change?
REGN TTM EBITDA was down -2.48% on September 30, 2025
What is 1-year change in REGN TTM EBITDA?
REGN TTM EBITDA is down -5.49% year-over-year
How far is REGN TTM EBITDA from its all-time high?
REGN TTM EBITDA is currently -53.74% below its historical high of $9.41B set on March 31, 2022
How does REGN TTM EBITDA rank versus sector peers?
REGN TTM EBITDA is higher than 97.45% of companies in Healthcare sector
When is REGN next earnings release?
The next earnings release for REGN is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- REGN Official Website www.regeneron.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/872589/000087258925000028/0000872589-25-000028-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/872589/000180422025000011/0001804220-25-000011-index.htm
- REGN Profile on Yahoo Finance finance.yahoo.com/quote/REGN
- REGN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/regn